UK falls from top spot in Economist Impact’s latest Health Inclusion Index


The second phase of the index, supported by Hareon, assesses the efforts of governments in 40 countries to ensure good health for all individuals.

London, November 20, 2023 /PRNewswire/ — The Economist Impact, a division of The Economist Group, today launched its second phase of working with organizations around the world to advance its mission. health comprehensiveness indexSupported by Haleon (LSE /NYSE: HLN) is a global leader in consumer health.The results of this phase show that health inclusiveness is declining globally, especially uk He fell from the top spot in Phase 1.

This index measures health comprehensiveness. It is defined as the process of removing personal, social, cultural and political barriers that prevent individuals and communities from enjoying good physical and mental health.

The index assesses 40 countries against 58 individual indicators across three areas: social health, comprehensive health systems, and empowerment of people and communities, and assesses efforts to empower societies. In addition, it aims to assess the status of health inclusion policies and the availability of key systems and infrastructure. Helping individuals and communities navigate the health care system and expanding access to marginalized and vulnerable populations.

The second phase of the index incorporates real-world experiences to measure the actual implementation of comprehensive health policies through a survey of more than 42,000 adults in 40 countries.

Key findings from Phase 2 of the Health Inclusivity Index include:

  • 85% of countries’ comprehensiveness scores worsened between Phase 1 and Phase 2, indicating a clear gap between policy and implementation.Effective and comprehensive health systems require the establishment of strong policy frameworks and the meaningful implementation of these measures in practice.
  • uk When we compare our health policy with experience on the ground, we lose our position as the healthiest country. While policies are an important foundation for health, it is their effective implementation and people’s experiences with them that reduce inequalities and improve population health outcomes.
  • In high-income countries, there is a large gap between comprehensive health policies and people’s experiences with them. In contrast, the difference is smaller in low-income and middle-income countries ( United Arab Emirates It is the only high-income country that does not follow this trend).High-income countries have developed and implemented ambitious health policies aimed at inclusion, but this push has created a policy-practice gap that will require focus, effort, and resources to close.
  • Marginalized groups face the greatest risk of exclusion in the health sector when gaps exist between health policy and policy experience. However, this is avoidable and requires the implementation of targeted interventions, which must be planned in collaboration with the target population.
  • More than three in five respondents to the Global Health Inclusivity Survey experienced barriers to accessing healthcare. The most common barriers include difficulty getting an appointment, distance and cost of travel, and lack of trust in health services.
  • Younger respondents are more likely to say they have been denied access to care and are more likely to believe that trust and cost are barriers to receiving care. More than one in five (21%) Gen Z and Millennial respondents have been denied access to care, compared to 14% of older respondents.
  • Low-income and lower-middle income countries promote greater inclusion through community-based health services.Respondents in low-income and lower-middle income countries were almost 10 percentage points more likely to have access to the five core community-level services considered in the index.

The top 10 Health Inclusivity Index rankings are: Australia, SwedenEngland, united states of america, France, Israel, Canada, South Korea, Germany, Switzerland and Thailand. With all but one country scoring below her 80 score, it is clear that significant efforts are needed to truly take root in health inclusivity.

Jonathan Bardwellsays Global Head of Policy and Insights at The Economist Impact.: “Measuring a country’s ability to provide quality health care requires not only an evaluation of its policies, but also the ability of its citizens to access health services. That’s why The Economist Impact’s Health Inclusiveness We are pleased to add real-world experience indicators to the index.The results of this phase show that the index still needs much improvement if high-income countries are to translate their policies into effective implementation. is showing.”

To access the full report, please visit: https://impact.economist.com/projects/health-inclusivity-index

About the influence of economists
Economist Impact combines the rigor of a think tank with the creativity of a media brand to engage a global and influential audience. We believe that evidence-based insights can widen debate, broaden perspectives, and drive progress. The services provided by Economist Impact previously existed within the Economist Group as separate organizations, including EIU Thought Leadership, EIU Public Policy, Economist Events, El Studios, and SignalNoise.

Our track record spans 75 years in 205 countries. In addition to creative storytelling, event expertise, design thinking solutions, and market-leading media products, we produce framework design, benchmarking, economic and social impact analysis, forecasting, and scenario modeling. What makes Economist Impact’s products unique on the market? For more information, please visit www.economistimpact.com.

About Hareon
Haleon (LSE /NYSE: HLN) is a global leader in consumer health, working with humanity to provide better everyday health. Haleon’s Product portfolio spans five major products Categories – Oral Health, Pain Relief, Respiratory Health, Digestive Health, Other, Vitamins, Minerals, and Supplements (VMS). Long-standing brands like Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum are built on trusted science, innovation and deep human understanding.

Learn more about. www.haleon.com.

Source The influence of The Economist



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *